LIN vs PODD · P/E 34, rev $33.99B vs P/E 34, rev $2.07B
Linde plc Ordinary Shares (LIN) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the LIN and PODD stock pages for the full models.
Not investment advice.